Cyprus approves the use of human COVID-19 medication molnupiravir to combat a local feline virus mutation causing feline infectious peritonitis resulting in numerous cat…
Cyprus approves the use of human COVID-19 medication molnupiravir to combat a local feline virus mutation causing feline infectious peritonitis resulting in numerous cat deaths locally. The government assures that there is no risk of depleting medication stocks for potential COVID-19 surges in the human population.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
Cyprus approves the use of human COVID-19 medication molnupiravir to combat a local feline virus mutation causing feline infectious peritonitis resulting in numerous cat deaths locally. The government assures that there is no risk of depleting medication stocks for potential COVID-19 surges in the human population.